Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 201

    1.

    Cancer stem cell heterogeneity in hereditary breast cancer.

    Wicha MS.

    Breast Cancer Res. 2008;10(2):105. Epub 2008 Apr 16.

    PMID:
    18423071
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics.

    Wright MH, Calcagno AM, Salcido CD, Carlson MD, Ambudkar SV, Varticovski L.

    Breast Cancer Res. 2008;10(1):R10. Epub 2008 Feb 1.

    PMID:
    18241344
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    3.

    Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics.

    Calcagno AM, Salcido CD, Gillet JP, Wu CP, Fostel JM, Mumau MD, Gottesman MM, Varticovski L, Ambudkar SV.

    J Natl Cancer Inst. 2010 Nov 3;102(21):1637-52. Epub 2010 Oct 8.

    PMID:
    20935265
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    4.

    Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy.

    Fillmore CM, Kuperwasser C.

    Breast Cancer Res. 2008;10(2):R25. Epub 2008 Mar 26.

    PMID:
    18366788
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    5.

    Multiple lineages of human breast cancer stem/progenitor cells identified by profiling with stem cell markers.

    Hwang-Verslues WW, Kuo WH, Chang PH, Pan CC, Wang HH, Tsai ST, Jeng YM, Shew JY, Kung JT, Chen CH, Lee EY, Chang KJ, Lee WH.

    PLoS One. 2009 Dec 21;4(12):e8377.

    PMID:
    20027313
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    6.

    Side population in the pancreatic cancer cell lines SW1990 and CFPAC-1 is enriched with cancer stem-like cells.

    Yao J, Cai HH, Wei JS, An Y, Ji ZL, Lu ZP, Wu JL, Chen P, Jiang KR, Dai CC, Qian ZY, Xu ZK, Miao Y.

    Oncol Rep. 2010 May;23(5):1375-82.

    PMID:
    20372854
    [PubMed - indexed for MEDLINE]
    7.

    Identification and characterization of cancer initiating cells from BRCA1 related mammary tumors using markers for normal mammary stem cells.

    Vassilopoulos A, Wang RH, Petrovas C, Ambrozak D, Koup R, Deng CX.

    Int J Biol Sci. 2008 May 4;4(3):133-42.

    PMID:
    18461147
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    8.

    Twist modulates breast cancer stem cells by transcriptional regulation of CD24 expression.

    Vesuna F, Lisok A, Kimble B, Raman V.

    Neoplasia. 2009 Dec;11(12):1318-28.

    PMID:
    20019840
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    9.

    A novel mouse model of human breast cancer stem-like cells with high CD44+CD24-/lower phenotype metastasis to human bone.

    Ling LJ, Wang S, Liu XA, Shen EC, Ding Q, Lu C, Xu J, Cao QH, Zhu HQ, Wang F.

    Chin Med J (Engl). 2008 Oct 20;121(20):1980-6.

    PMID:
    19080260
    [PubMed - indexed for MEDLINE]
    Free Article
    10.

    Mammary stem cells and breast cancer--role of Notch signalling.

    Farnie G, Clarke RB.

    Stem Cell Rev. 2007 Jun;3(2):169-75. Review.

    PMID:
    17873349
    [PubMed - indexed for MEDLINE]
    11.

    The CD44+/CD24- phenotype is enriched in basal-like breast tumors.

    Honeth G, Bendahl PO, Ringnér M, Saal LH, Gruvberger-Saal SK, Lövgren K, Grabau D, Fernö M, Borg A, Hegardt C.

    Breast Cancer Res. 2008;10(3):R53. Epub 2008 Jun 17.

    PMID:
    18559090
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    12.

    CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis.

    Hurt EM, Kawasaki BT, Klarmann GJ, Thomas SB, Farrar WL.

    Br J Cancer. 2008 Feb 26;98(4):756-65. Epub 2008 Feb 12.

    PMID:
    18268494
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    13.

    Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.

    Tanei T, Morimoto K, Shimazu K, Kim SJ, Tanji Y, Taguchi T, Tamaki Y, Noguchi S.

    Clin Cancer Res. 2009 Jun 15;15(12):4234-41. Epub 2009 Jun 9.

    PMID:
    19509181
    [PubMed - indexed for MEDLINE]
    Free Article
    14.

    Cancer stem cells as mediators of treatment resistance in brain tumors: status and controversies.

    Sakariassen PØ, Immervoll H, Chekenya M.

    Neoplasia. 2007 Nov;9(11):882-92. Review.

    PMID:
    18030356
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    15.

    Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy.

    Kakarala M, Wicha MS.

    J Clin Oncol. 2008 Jun 10;26(17):2813-20. Review.

    PMID:
    18539959
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    16.

    Semi-quantitative evaluation of CD44(+) /CD24(-) tumor cell distribution in breast cancer tissue using a newly developed fluorescence immunohistochemical staining method.

    Kai M, Onishi H, Souzaki M, Tanaka H, Kubo M, Tanaka M, Katano M.

    Cancer Sci. 2011 Dec;102(12):2132-8. doi: 10.1111/j.1349-7006.2011.02063.x. Epub 2011 Sep 14.

    PMID:
    21838786
    [PubMed - indexed for MEDLINE]
    17.

    Partial biological characterization of cancer stem-like cell line (WJ(2)) of human glioblastoma multiforme.

    Wang J, Wang X, Jiang S, Lin P, Zhang J, Wu Y, Xiong Z, Ren JJ, Yang H.

    Cell Mol Neurobiol. 2008 Nov;28(7):991-1003. Epub 2008 Mar 19.

    PMID:
    18350379
    [PubMed - indexed for MEDLINE]
    18.

    Molecular analysis reveals heterogeneity of mouse mammary tumors conditionally mutant for Brca1.

    Wright MH, Robles AI, Herschkowitz JI, Hollingshead MG, Anver MR, Perou CM, Varticovski L.

    Mol Cancer. 2008 Apr 7;7:29.

    PMID:
    18394172
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    19.

    Breast cancer stem cells and intrinsic subtypes: controversies rage on.

    Nakshatri H, Srour EF, Badve S.

    Curr Stem Cell Res Ther. 2009 Jan;4(1):50-60. Review.

    PMID:
    19149630
    [PubMed - indexed for MEDLINE]
    20.

    Cancer stem/progenitor cells are highly enriched in CD133+CD44+ population in hepatocellular carcinoma.

    Zhu Z, Hao X, Yan M, Yao M, Ge C, Gu J, Li J.

    Int J Cancer. 2010 May 1;126(9):2067-78.

    PMID:
    19711346
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk